Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This was the second lowest number of inspections per type of company made by the FDA in Washington, equalling 10.5% of all inspections in the second quarter of 2024.
The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.
The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Blood and Blood Products | 3 | -- | -- |
| Compliance: Devices | 2 | -- | -- |
| Drug Quality Assurance | 1 | -- | -- |
| Food Composition, Standards, Labeling and Econ | 1 | -- | -- |
| Foodborne Biological Hazards | 5 | 1 | -- |
| Human Cellular, Tissue, and Gene Therapies | -- | 1 | -- |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 1 | -- | -- |
| Postmarket Assurance: Devices | 1 | -- | -- |
| Technical Assistance: Food and Cosmetics | 7 | -- | -- |
Alerts Sign-up